>>> Oklo Inc. has signed a letter of intent to acquire Atomic Alchemy Inc. (23.0

Oklo Inc. has signed a letter of intent to acquire Atomic Alchemy Inc. (23.08)
  • Atomic Alchemy Inc., a U.S.-based company specializing in the production of radioisotopes. Oklo's fast reactor and fuel recycling technologies produce valuable coproducts, such as radioisotopes, through their respective processes.
  • The proposed acquisition builds upon the strategic partnership announced between Oklo and Atomic Alchemy earlier this year, demonstrating the opportunity to combine Oklo's power generation and fuel recycling capabilities with Atomic Alchemy's radioisotope production expertise to accelerate fuel production for Oklo's powerhouses, and to create new revenue streams from radioisotopes.
  • Key highlights of the proposed acquisition:
    • Leveraging Complementary Technology to Scale and Accelerate Fuel Availability: Radioisotopes can enhance the economics of nuclear fuel recycling and accelerate fuel availability for Oklo's powerhouses through the sales of high-value radioisotopes.
    • Expanding into an Attractive Market: This proposed acquisition diversifies Oklo's business and market reach into new sectors such as biotech, pharmaceuticals, space, defense, and semiconductors.
    • Establishing Domestic Radioisotope Production: Oklo and Atomic Alchemy intend to develop specialized radioisotope production capabilities with Oklo's fast reactor technologies and Atomic Alchemy's versatile irradiation reactor technologies to address urgent supply shortages in life-saving medical radioisotopes and advanced industrial applications.
    • Accelerating and Diversifying Oklo's Revenue Streams: Oklo expects to begin generating revenue from radioisotope production following the proposed acquisition, with initial revenues anticipated prior to completing the first radioisotope production reactors. This potential additional revenue stream is expected to diversify Oklo's income sources.
  • Oklo proposes to acquire Atomic Alchemy for $25 mln in an all-stock transaction (subject to customer adjustments). All Oklo shares issued to existing shareholders of Atomic Alchemy in connection with the transaction are expected to be subject to multi-year lock-ups. Upon closing, the proposed transaction is expected to have minimal immediate impact on Oklo's operating cost structure, and the proposed transaction is not expected to impact Oklo's previously announced 2024 outlook.